Helius Medical Tech Q4 2023 GAAP EPS $(1.47) Beats $(3.77) Estimate, Sales $134.000K Miss $246.333K Estimate
Helius Medical Tech Q4 2023 GAAP EPS $(1.47) Beats $(3.77) Estimate, Sales $134.000K Miss $246.333K Estimate
Helius Medical Tech 2023年第四季度GAAP每股收益（1.47）超過預期（3.77 美元），銷售額爲13.4萬美元，低於預期的246.333萬美元
Helius Medical Tech (NASDAQ:HSDT) reported quarterly losses of $(1.47) per share which beat the analyst consensus estimate of $(3.77) by 61.01 percent. The company reported quarterly sales of $134.000 thousand which missed the analyst consensus estimate of $246.333 thousand by 45.60 percent. This is a 52.48 percent decrease over sales of $282.000 thousand the same period last year.
Helius Medical Tech（納斯達克股票代碼：HSDT）公佈的季度虧損爲每股1.47美元，比分析師普遍預期的3.77美元（3.77美元）高出61.01％。該公司公佈的季度銷售額爲13.4萬美元，比分析師普遍預期的246,333美元低45.60％。這比去年同期的28.2萬美元的銷售額下降了52.48％。